Search Results

Health Care

Is Glaucoma Policy Short-Sighted?

Redefining innovation to keep an eye on patient access.

Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; Henisk Falah, BS; and David Solá-Del Valle, MD

Seen & Heard

Feature

EyeSustain

David F. Chang, MD, and Cassandra L. Thiel, PhD

Peer Review

Elevated IOP After Laser Treatment

Laser procedures that are ordinarily safe can sometimes have unexpected outcomes.

Frank Cao, MD, and Inci Irak Dersu, MD

Feature

Boris Malyugin, MD, PHD

Interviewed by Laura Straub, Editor-in-Chief, CRST/CRST Europe

International Perspectives

Reaching out

Grow your skills and help surgeons in the developing world put a dent in the backlog of cataract cases.

Zaiba Malik, MD

The Dark Side of Medication

Many systemic and topical drugs can cause or worsen dry eye disease.

Sarah Marshall, PhD, and Robert Noecker, MD, MBA

How I Plan to Use a Trabecular Microbypass Stent in My Practice

Glaucoma Today asked four surgeons to share their expectations.

David F. Chang, MD; Richard A. Lewis, MD; Richard L. Lindstrom, MD; and Barbara A. Smit, MD, PhD

How I Plan to Use a Trabecular Microbypass Stent in My Practice

Glaucoma Today asked four surgeons to share their expectations.

David F. Chang, MD; Richard A. Lewis, MD; Richard L. Lindstrom, MD; and Barbara A. Smit, MD, PhD

Glaucoma and Genomic Medicine

Research is bringing clinicians closer to personalized treatment based on risk alleles and the interaction with biological networks and environmental factors.

Sayoko E. Moroi, MD, PhD, and Julia E. Richards, PhD

The Intraoperative Floppy Iris Syndrome

Surgical strategies for a new small pupil syndrome.

David F. Chang, MD

The Intraoperative Floppy Iris Syndrome

Surgical strategies for a new small pupil syndrome.

David F. Chang, MD

The Intraoperative Floppy Iris Syndrome

Surgical strategies for a new small pupil syndrome.

David F. Chang, MD